DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2221362/axon-enterprise-axon-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2221362 Feb 05, 2024 - Axon Enterprise (AXON) closed the most recent trading day at $257.47, moving +0.19% from the previous trading session. 0

https://www.zacks.com/stock/news/2232757/here-s-what-key-metrics-tell-us-about-axon-axon-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2232757 Feb 27, 2024 - The headline numbers for Axon (AXON) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.fool.com/earnings/call-transcripts/2024/02/28/axon-enterprise-axon-q4-2023-earnings-call-transcr/?source=iedfolrf0000001 Feb 27, 2024 - AXON earnings call for the period ending December 31, 2023. 0

https://www.zacks.com/stock/news/2234706/axon-enterprise-axon-gains-from-business-strength-amid-risks?cid=CS-ZC-FT-analyst_blog|zer_report_update-2234706 Mar 01, 2024 - Axon Enterprise (AXON) gains from solid momentum in its businesses and robust product offerings. However, rising operating expenses remain concerns. 0

https://seekingalpha.com/news/4077685-boston-scientific-pulls-refiles-hsr-notification-for-axonics-deal?source=feed_sector_healthcare Mar 08, 2024 - Boston Scientific has refiled its HSR notification for the $3.7 billion acquisition of Axonics, aiming for a first half close in 2024. 0

https://www.zacks.com/stock/news/2242077/new-to-investing-this-1-industrial-products-stock-could-be-the-perfect-starting-point?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2242077 Mar 18, 2024 - Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service. 0

https://seekingalpha.com/news/4082383-medtronic-claims-upheld-in-two-patents-spat-axonics?source=feed_sector_healthcare Mar 21, 2024 - TWO Medtronic patents for sacral neuromodulation technologies have been upheld by PTAB, affirming their validity. Read more here. 0

https://www.zacks.com/stock/news/2248008/all-you-need-to-know-about-axonics-axnx-rating-upgrade-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2248008 Mar 29, 2024 - Axonics (AXNX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). 0

https://www.zacks.com/stock/news/2258698/will-axon-axon-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2258698 Apr 19, 2024 - Axon (AXON) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 0

https://www.zacks.com/stock/news/2262648/here-s-how-you-should-play-3m-mmm-stock-ahead-of-q1-earnings?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2262648 Apr 25, 2024 - Weakness in the Safety and Industrial unit is likely to dent 3M's (MMM) first-quarter 2024 results. However, strength in the Transportation and Electronics unit is expected to provide some relief. 0